The effect of locally administered PGE2 on the contractility of the nonpregnant human uterus in vivo.
The effect of locally administered prostaglandin E2 on the sensitivity and reactivity of the nonpregnant human uterus during the menstrual cycle was studied in seven women. An increase in uterine contractility in response to as little as 0.25 mug PGE2 could be observed during both the mid-proliferative and mid-secretory phases of the menstrual cycle, but around ovulation a marked decrease in sensitivity to PGE2 was noted. An inhibition of uterine motility was observed during menstruation in response to 30--40 mug PGE2. Endogenous E prostaglandin normally occurs in the secretory endometrium in levels comparable to the amount of exogenous PGE2 which elicited increased or decreased uterine activity in this study. These findings suggest that PGE2 may play an important role in the cyclical regulation of uterine motility during the menstrual cycle.
D003864:Depression, Chemical; D004717:Endometrium / Q000378:metabolism; D005260:Female; D006801:Humans; D008598:Menstruation; D010060:Ovulation; D011458:Prostaglandins E / Q000378:metabolism / Q000494:pharmacology*; D013268:Stimulation, Chemical; D014590:Uterine Contraction / Q000187:drug effects*
D011458:Prostaglandins E